Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash & Equivalents (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.50% |
| Sep 30, 2025 | 43.55% |
| Jun 30, 2025 | -6.07% |
| Mar 31, 2025 | 55.54% |
| Dec 31, 2024 | -37.44% |
| Sep 30, 2024 | 1.25% |
| Jun 30, 2024 | 287.02% |
| Mar 31, 2024 | -48.87% |
| Dec 31, 2023 | 385.73% |
| Sep 30, 2023 | -69.85% |
| Jun 30, 2023 | -9.61% |
| Mar 31, 2023 | 92.49% |
| Dec 31, 2022 | -69.42% |
| Sep 30, 2022 | -42.87% |
| Jun 30, 2022 | 68.31% |
| Mar 31, 2022 | -29.10% |
| Dec 31, 2021 | -50.82% |
| Sep 30, 2021 | 15.20% |
| Jun 30, 2021 | 852.17% |
| Mar 31, 2021 | -96.04% |